rs1051393
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001289125.3(IFNAR2):c.28T>G(p.Phe10Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.335 in 1,606,830 control chromosomes in the GnomAD database, including 95,222 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F10I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001289125.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFNAR2 | NM_001289125.3 | c.28T>G | p.Phe10Val | missense_variant | 2/9 | ENST00000342136.9 | |
IFNAR2-IL10RB | NM_001414505.1 | c.28T>G | p.Phe10Val | missense_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFNAR2 | ENST00000342136.9 | c.28T>G | p.Phe10Val | missense_variant | 2/9 | 1 | NM_001289125.3 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.317 AC: 48202AN: 151950Hom.: 8274 Cov.: 32
GnomAD3 exomes AF: 0.383 AC: 95264AN: 248934Hom.: 19832 AF XY: 0.386 AC XY: 51937AN XY: 134618
GnomAD4 exome AF: 0.337 AC: 490087AN: 1454762Hom.: 86938 Cov.: 31 AF XY: 0.341 AC XY: 247021AN XY: 723956
GnomAD4 genome ? AF: 0.317 AC: 48244AN: 152068Hom.: 8284 Cov.: 32 AF XY: 0.329 AC XY: 24420AN XY: 74322
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 69% of patients studied by a panel of primary immunodeficiencies. Number of patients: 66. Only high quality variants are reported. - |
Immunodeficiency 45 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Mortality risk in patients with severe coronavirus disease (COVID-19) Other:1
association, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 06, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at